United Therapeutics Corp Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 08/07/2026 | 5.29 M | $2.87 B | -1.95% | 12.43% |
| AVORO CAPITAL ADVISORS LLC | 08/14/2026 | 2.78 M | $1.51 B | 5.62% | 6.52% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 1.92 M | $1.04 B | -4.21% | 4.51% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 1.92 M | $1.04 B | -2.01% | 4.50% |
| STATE STREET CORP | 08/07/2026 | 1.90 M | $1.03 B | 2.93% | 4.46% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 1.71 M | $925.85 M | -4.38% | 4.01% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 1.38 M | $747.20 M | -39.10% | 3.24% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 996.60 K | $538.86 M | -19.17% | 2.34% |
| JUPITER TOPCO LLC | 08/14/2026 | 831.13 K | $450.14 M | 100.00% | 1.95% |
| NORGES BANK | 08/12/2026 | 694.75 K | $376.44 M | 100.00% | 1.63% |
| ASSETMARK, INC | 07/30/2026 | 624.07 K | $338.14 M | 1.30% | 1.46% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2026 | 546.00 K | $294.64 M | -33.92% | 1.28% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 527.90 K | $286.05 M | 2.96% | 1.24% |
| FMR LLC | 08/13/2026 | 473.41 K | $256.51 M | -10.40% | 1.11% |
| INVESCO LTD. | 08/14/2026 | 473.11 K | $256.34 M | -22.23% | 1.11% |
| BAILLIE GIFFORD & CO | 08/06/2026 | 467.21 K | $253.15 M | 9.13% | 1.10% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 08/14/2026 | 457.00 K | $247.62 M | 0.00% | 1.07% |
| MORGAN STANLEY | 08/13/2026 | 436.70 K | $236.62 M | 6.70% | 1.03% |
| VESTAL POINT CAPITAL, LP | 08/14/2026 | 435.00 K | $235.70 M | 480.00% | 1.02% |
| NORTHERN TRUST CORP | 08/13/2026 | 430.84 K | $233.44 M | -1.31% | 1.01% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 409.07 K | $221.65 M | 166.72% | 0.96% |
| CAPTION MANAGEMENT, LLC | 08/14/2026 | 378.20 K | $204.92 M | -7.76% | 0.89% |
| CAPTION MANAGEMENT, LLC | 08/14/2026 | 366.60 K | $198.63 M | -45.05% | 0.86% |
| FRANKLIN RESOURCES INC | 08/13/2026 | 340.28 K | $184.37 M | 22.41% | 0.80% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 326.30 K | $176.80 M | -31.45% | 0.77% |
| SWEDBANK AB | 07/15/2026 | 323.00 K | $175.01 M | -1.26% | 0.76% |
| ACADIAN ASSET MANAGEMENT LLC | 08/13/2026 | 318.32 K | $172.43 M | 6.03% | 0.75% |
| CITADEL ADVISORS LLC | 09/02/2026 | 304.69 K | $165.09 M | -15.51% | 0.72% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 297.16 K | $161.01 M | -1.10% | 0.70% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 297.16 K | $161.01 M | 100.00% | 0.70% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 294.41 K | $159.52 M | -10.55% | 0.69% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 293.00 K | $158.76 M | -17.88% | 0.69% |
| EVERSEPT PARTNERS, LP | 08/14/2026 | 287.67 K | $155.87 M | 8.85% | 0.68% |
| JANE STREET GROUP, LLC | 08/14/2026 | 285.93 K | $154.92 M | 10,263.39% | 0.67% |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 08/14/2026 | 284.78 K | $154.30 M | -17.13% | 0.67% |
| JPMORGAN CHASE & CO | 08/12/2026 | 275.36 K | $151.01 M | -5.58% | 0.65% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 268.48 K | $145.47 M | 0.19% | 0.63% |
| LSV ASSET MANAGEMENT | 08/06/2026 | 268.37 K | $145.41 M | -32.68% | 0.63% |
| PICTET ASSET MANAGEMENT HOLDING SA | 07/30/2026 | 267.85 K | $145.16 M | -13.38% | 0.63% |
| CITIGROUP INC | 08/03/2026 | 262.20 K | $142.07 M | 11.28% | 0.62% |
| CITADEL ADVISORS LLC | 09/02/2026 | 249.40 K | $135.13 M | 43.83% | 0.59% |
| FIRST TRUST ADVISORS LP | 08/11/2026 | 249.06 K | $134.95 M | -7.95% | 0.58% |
| LORD, ABBETT & CO. LLC | 08/14/2026 | 244.32 K | $132.38 M | -2.38% | 0.57% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 243.44 K | $131.91 M | -39.96% | 0.57% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2026 | 234.61 K | $139.12 M | 6.33% | 0.55% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2026 | 233.64 K | $126.59 M | 89.27% | 0.55% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 08/11/2026 | 225.59 K | $122.23 M | 20.51% | 0.53% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 08/12/2026 | 220.70 K | $119.58 M | -21.29% | 0.52% |
| UBS GROUP AG | 08/13/2026 | 220.62 K | $119.54 M | -6.81% | 0.52% |
| AMUNDI | 08/11/2026 | 219.09 K | $118.71 M | 48.44% | 0.51% |
United Therapeutics Corp institutional Ownership - FAQ's
During the previous two years, 1239 institutional investors and hedge funds held shares of United Therapeutics Corp. The most heavily invested institutionals were:
BlackRock, Inc.: 5.29 M
Avoro Capital Advisors LLC: 2.78 M
VANGUARD PORTFOLIO MANAGEMENT LLC: 1.92 M
VANGUARD CAPITAL MANAGEMENT LLC: 1.92 M
STATE STREET CORP: 1.9 M
RENAISSANCE TECHNOLOGIES LLC: 1.71 M
98.58% of United Therapeutics Corp stock is owned by institutional investors.
Institutional investors have bought a total of 63.00 M shares in the last 24 months. This purchase volume represents approximately $33.34 B in transactions.